Medacta Group SA (MEDGF)
83.91
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Medacta Group Price to Book Value: 4.583 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 4.583 |
| April 24, 2024 | 4.583 |
| April 23, 2024 | 4.583 |
| April 22, 2024 | 4.583 |
| April 19, 2024 | 4.583 |
| April 18, 2024 | 4.583 |
| April 17, 2024 | 4.583 |
| April 16, 2024 | 4.583 |
| April 15, 2024 | 4.583 |
| April 12, 2024 | 4.583 |
| April 11, 2024 | 4.583 |
| April 10, 2024 | 4.583 |
| April 09, 2024 | 4.583 |
| April 08, 2024 | 4.583 |
| April 05, 2024 | 4.583 |
| April 04, 2024 | 4.583 |
| April 03, 2024 | 4.583 |
| April 02, 2024 | 4.583 |
| April 01, 2024 | 4.583 |
| March 28, 2024 | 4.583 |
| March 27, 2024 | 4.583 |
| March 26, 2024 | 4.583 |
| March 25, 2024 | 4.583 |
| March 22, 2024 | 4.583 |
| March 21, 2024 | 4.583 |
| Date | Value |
|---|---|
| March 20, 2024 | 4.583 |
| March 19, 2024 | 4.583 |
| March 18, 2024 | 4.583 |
| March 15, 2024 | 4.583 |
| March 14, 2024 | 4.583 |
| March 13, 2024 | 4.583 |
| March 12, 2024 | 4.583 |
| March 11, 2024 | 4.583 |
| March 08, 2024 | 4.583 |
| March 07, 2024 | 4.583 |
| March 06, 2024 | 4.583 |
| March 05, 2024 | 4.583 |
| March 04, 2024 | 4.583 |
| March 01, 2024 | 4.583 |
| February 29, 2024 | 4.583 |
| February 28, 2024 | 4.583 |
| February 27, 2024 | 4.583 |
| February 26, 2024 | 4.583 |
| February 23, 2024 | 4.583 |
| February 22, 2024 | 4.583 |
| February 21, 2024 | 4.583 |
| February 20, 2024 | 4.583 |
| February 16, 2024 | 4.583 |
| February 15, 2024 | 4.583 |
| February 14, 2024 | 4.583 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.583
Minimum
Jan 02 2024
17.96
Maximum
Jun 27 2019
7.532
Average
5.686
Median
Jan 03 2023
Price to Book Value Benchmarks
| AC Immune SA | 1.195 |
| CRISPR Therapeutics AG | 2.395 |
| Addex Therapeutics Ltd | 10.96 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.6069 |
Price to Book Value Related Metrics
| PE Ratio | 32.62 |
| PS Ratio | 3.031 |
| Price | 83.91 |
| Earnings Yield | 3.07% |
| Market Cap | 1.672B |
| Operating PE Ratio | 20.77 |
| Normalized PE Ratio | 32.62 |